Naples Global Advisors, LLC Astrazeneca PLC Transaction History

Naples Global Advisors, LLC

$1.24 Billion
Q3 2025

A detailed history of Naples Global Advisors, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Naples Global Advisors, LLC holds 53,033 shares of AZN stock, worth $4.74 Million. This represents 0.33% of its overall portfolio holdings.

Number of Shares

53,033

Previous 53,289 0.48%

Holding current value

$4.74 Million

Previous $3.72 Million 9.27%

% of portfolio

0.33%

Previous 0.33%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 30, 2025	SELL	$68.72 - $82.11 $17,592 - $21,020	-256 Reduced 0.48%	53,033 $4.07 Million
Q2 2025 Jul 18, 2025	SELL	$64.87 - $75.0 $43,852 - $50,700	-676 Reduced 1.25%	53,289 $3.72 Million
Q1 2025 Apr 10, 2025	SELL	$65.37 - $77.96 $53,211 - $63,459	-814 Reduced 1.49%	53,965 $3.97 Million
Q4 2024 Jan 29, 2025	BUY	$63.2 - $79.58 $19,023 - $23,953	301 Added 0.55%	54,779 $3.59 Million
Q3 2024 Oct 24, 2024	BUY	$76.67 - $87.62 $53,669 - $61,334	700 Added 1.3%	54,478 $4.24 Million

Q2 2024 Jul 18, 2024	BUY	$66.81 - $80.83 $24,719 - $29,907	370 Added 0.69%	53,778 $4.19 Million
Q1 2024 Apr 29, 2024	BUY	$61.03 - $69.57 $292,333 - $333,240	4,790 Added 9.85%	53,408 $3.62 Million
Q4 2023 Jan 11, 2024	BUY	$61.89 - $69.28 $242,299 - $271,231	3,915 Added 8.76%	48,618 $3.27 Million
Q3 2023 Oct 16, 2023	BUY	$64.85 - $71.7 $120,296 - $133,003	1,855 Added 4.33%	44,703 $3.03 Million
Q2 2023 Jul 17, 2023	SELL	$69.91 - $75.81 $2,936 - $3,184	-42 Reduced 0.1%	42,848 $3.07 Million
Q1 2023 Apr 17, 2023	BUY	$63.15 - $71.6 $57,087 - $64,726	904 Added 2.15%	42,890 $2.98 Million
Q4 2022 Jan 20, 2023	BUY	$54.21 - $70.44 $50,144 - $65,157	925 Added 2.25%	41,986 $0
Q3 2022 Oct 20, 2022	BUY	$53.02 - $135.75 $13,255 - $33,937	250 Added 0.61%	41,061 $2.25 Million
Q2 2022 Aug 11, 2022	BUY	$59.26 - $71.14 $40,178 - $48,232	678 Added 1.69%	40,811 $2.7 Million
Q1 2022 Apr 28, 2022	BUY	$55.72 - $67.12 $33,432 - $40,272	600 Added 1.52%	40,133 $2.66 Million
Q4 2021 Feb 04, 2022	BUY	$54.02 - $63.83 $9,453 - $11,170	175 Added 0.44%	39,533 $2.3 Million
Q3 2021 Oct 25, 2021	BUY	$55.56 - $60.79 $22,224 - $24,316	400 Added 1.03%	39,358 $2.36 Million
Q2 2021 Aug 06, 2021	BUY	$48.42 - $60.18 $153,733 - $191,071	3,175 Added 8.87%	38,958 $2.33 Million
Q1 2021 May 10, 2021	SELL	$47.16 - $54.44 $3,065 - $3,538	-65 Reduced 0.18%	35,783 $1.78 Million
Q4 2020 Feb 08, 2021	BUY	$48.52 - $58.02 $27,899 - $33,361	575 Added 1.63%	35,848 $1.79 Million
Q3 2020 Oct 26, 2020	BUY	$53.07 - $61.1 $14,063 - $16,191	265 Added 0.76%	35,273 $1.93 Million
Q2 2020 Aug 04, 2020	BUY	$43.1 - $55.31 $103,440 - $132,744	2,400 Added 7.36%	35,008 $1.85 Million
Q1 2020 Apr 27, 2020	BUY	$37.79 - $51.33 $26,453 - $35,931	700 Added 2.19%	32,608 $1.46 Million
Q4 2019 Feb 05, 2020	SELL	$42.46 - $50.46 $3,184 - $3,784	-75 Reduced 0.23%	31,908 $1.59 Million
Q2 2019 Jul 10, 2019	BUY	$37.28 - $41.68 $33,552 - $37,512	900 Added 2.9%	31,983 $1.32 Million
Q1 2019 Apr 29, 2019	SELL	$35.49 - $43.02 $27,362 - $33,168	-771 Reduced 2.42%	31,083 $1.26 Million
Q4 2018 Feb 01, 2019	SELL	$36.86 - $41.49 $65,573 - $73,810	-1,779 Reduced 5.29%	31,854 $1.22 Million
Q3 2018 Nov 13, 2018	BUY	$34.76 - $39.72 $39,974 - $45,678	1,150 Added 3.54%	33,633 $1.33 Million
Q2 2018 Jul 23, 2018	BUY	$34.55 - $37.05 $72,555 - $77,805	2,100 Added 6.91%	32,483 $1.14 Million
Q1 2018 Apr 17, 2018	BUY	$32.97 - $36.63 $8,242 - $9,157	250 Added 0.83%	30,383 $1.06 Million
Q4 2017 Jan 19, 2018	BUY	$32.09 - $34.78 $56,221 - $60,934	1,752 Added 6.17%	30,133 $1.05 Million
Q3 2017 Oct 16, 2017	BUY	$28.96 - $34.0 $821,913 - $964,954	28,381	28,381 $962,000

Others Institutions Holding AZN

# of Institutions

1,501

Shares Held

500M

Call Options Held

5.59M

Put Options Held

3.18M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $277B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Naples Global Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Naples Global Advisors, LLC with notifications on news.

Account

Naples Global Advisors, LLC Astrazeneca PLC Transaction History